Repression of p27(kip1) synthesis by platelet-derived growth factor in BALB/c 3T3 cells

Molecular and Cellular Biology

Volumn 16, Issue 8, 1996, Pages 4327-4336

  Agrawal, Deepak ^a,b   Hauser, Paul ^a   McPherson, Fiona ^a,b   Dong, Feng ^a,b   Garcia, Anna ^a   Pledger, W J ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; CYCLIN D3; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; MESSENGER RNA; METHIONINE; PLATELET DERIVED GROWTH FACTOR; PROTEIN P27; UNCLASSIFIED DRUG; CDKN1B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICROTUBULE ASSOCIATED PROTEIN; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE PHASE; CONTROLLED STUDY; GROWTH INHIBITION; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REPRESSOR GENE; TRANSLATION REGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL CYCLE; CELL STRAIN 3T3; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY;

3T3 CELLS; ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; GENE EXPRESSION; MICE; MICE, INBRED BALB C; MICROTUBULE-ASSOCIATED PROTEINS; ONCOGENE PROTEINS; PLATELET-DERIVED GROWTH FACTOR; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 0029666094     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.8.4327     Document Type: Article

References (79)

1. Aaronson, S. A. 1991. Growth factors and cancer. Science 254:1146-1153.
2. Agrawal, D. K., F. Dong, Y. Z. Wang, D. Kayda, and W. J. Pledger. 1995. Regulation of cyclin E and p27kip during mitosis in Balb/c 3T3 cells. Cell Growth Differ. 6:1199-1205.
3. 1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589-23597.
4. Bullrich, F., T. K. MacLachlan, N. Sang, T. Druck, M. L. Veronese, S. L. Allen, N. Chiorazzi, A. Koff, K. Heubner, C. M. Croce, et al. 1995. Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer. Cancer Res. 55:1199-1205.
5. Chen, J., P. K. Jackson, M. W. Kirschner, and A. Dutta. 1995. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature (London) 374:386-388.
6. Datto, M. B., Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and X. F. Wang. 1995. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92:5545-5549.
7. De Bondt, H. L., J. Rosenblatt, J. Jancarik, H. D. Jones, D. O. Morgan, and S. H. Kim. 1993. Crystal structure of cyclin-dependent kinase 2. Nature (London) 363:595-602.
8. 1 cyclin-dependent kinase activity. Genes Dev. 9:2873-2887.
9. Desai, D., Y. Gu, and D. O. Morgan. 1992. Activation of human cyclin-dependent kinases in vitro. Mol. Biol. Cell 3:571-582.
10. Dou, Q. P., A. H. Levin, S. Zhao, and A. B. Pardee. 1993. Cyclin E and cyclin A as candidates for the restriction point protein: Cancer Res. 53:1493-1497.
11. el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
12. Elledge, S. J., and J. W. Harper. 1995. Cdk inhibitors: on the threshold of checkpoints and development. Curr. Opin. Cell Biol. 6:847-852.
13. Elledge, S. J., R. Richman, F. L. Hall, R. T. Williams, N. Lodgson, and J. W. Harper. 1992. CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle. Proc. Natl. Acad. Sci. USA 89:2907-2911.
14. 1 cell-cycle arrest. Genes Dev. 9:204-217.
15. Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J. Kalo, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
16. Firpo, E. J., A. Kof, M. J. Solomon, and J. M. Roberts. 1994. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 14:4889-4901.
17. Flores-Rozas, H., Z. Kelman, F. B. Dean, Z. Q. Pan, J. W. Harper, S. J. Elledge, M. O'Donnell, and J. Hurwitz. 1994. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc. Natl. Acad. Sci. USA 91:8655-8659.
18. 17a. Garcia, A., D. Agrawal, and W. J. Medger. Unpublished data.
19. Girard, F., U. Strausfeld, A. Fernandez, and N. J. Lamb. 1991. Cyclin A is required for the onset of DNA replication in mammalian fibroblasls. Cell 67:1169-1179.
20. Goubin, F., and B. Ducommun. 1995. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. Oncogene 10:2281-2287.
21. Gu, Y., J. Rosenblatt, and D. O. Morgan. 1992. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11:3995-4005.
22. Hamaguchi, J. R., R. A. Tobey, J. Pines, H. A. Crissman, T. Hunter, and E. M. Bradbury. 1992. Requirement for p34cdc2 kinase is restricted to mitosis in the mammalian cdc2 mutant FT210. J. Cell Biol. 117:1041-1053.
23. 1 cyclin-dependent kinases. Cell 75:805-816.
24. Hirai, H., M. F. Roussel, J. Y. Kato, R. A. Ashmun, and C. J. Sherr. 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15:2672-2681.
25. Jackson, P. K., S. Chevalier, M. Philippe, and M. W. Kirschner. 1995. Early events in DNA replication require cyclin E and are blocked by p21cip1. J. Cell Biol. 130:755-769.
26. Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331-342.
27. Kato, J. Y., M. Matsuoka, K. Polyak, J. Massague, and C. I. Sherr. 1994. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487-496.
28. 3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene 10:159-166.
29. Kiyokawa, H., V. M. Richon, R. A. Rifkind, and P. A. Marks. 1994. Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol. Cell Biol. 14:7195-7203.
30. Kobayashi, H., R. Golsteyn, R. Poon, E. Stewart, J. Gannon, J. Minshull, R. Smith, and T. Hunt. 1991. Cyclins and their partners during Xenopus oocyte maturation. Cold Spring Harbor Symp. Quant. Biol. 56:437-447.
31. Koff, A., F. Cross, A. Fisher, J. Schumacher, K. Leguellec, M. Philippe, and J. M. Roberts. 1991. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66:1217-1228.
32. Koff, A., A. Giordano, D. Desai, K. Yamashita, J. W. Harper, S. Elledge, T. Nishimoto, D. O. Morgan, B. R. Franza, and J. M. Roberts. 1992. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257:1689-1694.
33. 1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science 260:536-539.
34. Lee, M. H., I. Reynisdottir, and J. Massague. 1995. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9:639-649.
35. Lees, E., B. Faha, V. Dulic, S. I. Reed, and E. Harlow. 1992. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev. 6:1874-1885.
36. Lehner, C. F., N. Yakubovich, and P. H. O'Farrell. 1991. Exploring the role of Drosophila cyclin A in the regulation of S phase. Cold Spring Harbor Symp. Quant. Biol. 56:465-475.
37. 1 progression in NIH 3T3 cells. Mol. Cell. Biol. 15:3654-3663.
38. Luo, Y., J. Hurwitz, and J. Massague. 1995. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature (London) 375:159-161.
39. Macleod, K. F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelslein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9:935-944.
40. Marraccino, R. L., E. J. Firpo, and J. M. Roberts. 1992. Activation of the p34 CDC2 protein kinase at the start of S phase in the human cell cycle. Mol. Biol. Cell. 3:389-401.
41. Massague, J., and K. Polyak. 1995. Mammalian antiproliferative signals and their targets. Curr. Opin. Genet. Dev. 5:91-96.
42. Matsuoka, S., M. C. Edwards, C. Bai, S. Parker, P. Zhang, A. Baldini, J. W. Harper, and S. J. Elledge. 1995. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:650-662.
43. 1 cyclins. Cell 71:323-334.
44. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
45. 1 phase of the cell cycle. Cell 65:701-713.
46. 1. Cold Spring Harbor Symp. Quant. Biol. 56:69-74.
47. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077-2086.
48. Morgan, D. O. 1995. Principles of CDK regulation. Nature (London) 374: 131-134.
49. Nakanishi, M., R. S. Robetorye, G. R. Adams, O. M. Pereira-Smith, and J. R. Smith. 1995. Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1. EMBO J. 14:555-563.
50. Nakanishi, M., R. S. Robetorye, O. M. Pereira-Smith, and J. R. Smith. 1995. The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding hut docs not appear to be required for growth inhibition. J. Biol. Chem. 270:17060-17063.
51. Nourse, J., E. Firpo, W. M. Flanagan, S. Coats, K. Polyak, M. H. Lee, J. Massague, G. R. Crabtree, and J. M. Roberts. 1994. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (London) 372:570-573.
52. Ohtani, K., J. DeGregori, and J. R. Nevins. 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA 92:12146-12150.
53. 1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
54. Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685.
55. Pines, J. 1993. Cyclins and their associated cyclin-dependent kinases in the human cell cycle. Biochem. Soc. Trans. 21:921-925.
56. Pines, J. 1994. The cell cycle kinases. Semin. Cancer Biol. 5:305-313.
57. Pledger, W. J., C. D. Stiles, H. N. Antoniades, and C. D. Scher. 1977. Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process. Proc. Natl. Acad. Sci. USA 74: 4481-4485.
58. Pledger, W. J., C. D. Stiles, H. N. Antoniades, and C. D. Scher. 1978. An ordered sequence of events is required before BALB/C-3T3 cells become committed to DNA synthesis. Proc. Natl. Acad. Sci. USA 75:2839-2843.
59. Polyak, K., J. Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff. 1994. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8:9-22.
60. Polyak, K., M. H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
61. Poon, R. Y. C., H. Toyoshima, and T. Hunter. 1995. Redistribution of the cdk inhibitor p27 between different cyclin cdk complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell 6:1197-1213.
62. 1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
63. 1 phase cyclin dependent kinases by transforming growth factor beta 1. J. Cell. Biochem. 56:418-425.
64. Reynisdottir, I., K. Polyak, A. Iavarone, and J. Massague. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9:1831-1845.
65. Rosenblatt, J., Y. Gu, and D. O. Morgan. 1992. Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc. Natl. Acad. Sci. USA 89:2824-2828.
66. Rozengurt, E. 1992. Growth factors and cell proliferation. Curr. Opin. Cell Biol. 4:161-165.
67. Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (London) 366:704-707.
68. Sherr, C. J., H. Matsushime, and M. F. Roussel. 1992. Regulation of CYL/ cyclin D genes by colony-stimulating factor 1. Ciba Found. Symp. 170:209-219.
69. 1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
70. Soos, T. J., H. Kiyokawa, J. S. Yan, M. S. Rubin, A. Giordano, A. DeBlasio, S. Bottega, B. Wong, J. Mendelsohn, and A. Koff. 1996. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ. 7:135-146.
71. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
72. Warbrick, E., D. P. Lane, D. M. Glover, and L. S. Cox. 1995. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Curr. Biol. 5:275-282.
73. Kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts. J. Biol. Chem. 271:11253-11260.
74. Winston, J., Y. Z. Wang, and W. J. Pledger. 1996. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12:127-134.
75. Won, K. A., Y. Xiong, D. Beach, and M. Z. Gilman. 1992. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl. Acad. Sci. USA 89:9910-9914.
76. Xiong, Y., H. Zhang, and D. Beach. 1993. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7:1572-1583.
77. Zerfass, K., A. Schulze, D. Spilkovsky, V. Friedman, B. Henglein, and P. Jansen-Durr. 1995. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J. Virol. 69:6389-6399.
78. Zhang, H., G. J. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750-1758.
79. Zhu, L., G. Enders, J. A. Lees, R. L. Beijersbergen, R. Bernards, and E. Harlow. 1995. The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J. 14:1904-1913.